Tamoxifen, endometrial cancer and levonorgestrel intra-uterine device

By Espie M.  

Gynecology Obstetrique & Fertilite, Vol. 31, Iss. 10, 2003-10 ,pp. : 867-871

Elsevier

Access to resources Recommend Favorite

Should endometrial hyperplasia be regarded as a reason for abnormal uterine bleeding in users of the intrauterine contraceptive device?

By Özalp S.   Kabukcuoglu S.   Tanir H. M.  

The European Journal of Contraception and Reproductive Health Care, Vol. 8, Iss. 1, 2003-03 ,pp. : 17-20

Informa Healthcare

Access to resources Recommend Favorite

An evaluation of the simultaneous use of the levonorgestrel-releasing intrauterine device (LNG-IUS, Mirena®) combined with endometrial ablation in the management of menorrhagia

By Vaughan D.   Byrne P.  

Journal of Obstetrics & Gynaecology, Vol. 32, Iss. 4, 2012-05 ,pp. : 372-374

Informa Healthcare

Access to resources Recommend Favorite

The intrauterine device and its dynamics

By Van Os W.A.A.  

Advances in Contraception, Vol. 15, Iss. 2, 1999-01 ,pp. : 119-132

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of three catheters for endometrial sampling during sonohysterography: results of a preliminary study

By Bernard J. P.   Metzger Ulrike   Camatte Sophie   Robin F.   Vildé Françoise   Taurelle R.   Lécuru F.  

Journal of Obstetrics & Gynaecology, Vol. 22, Iss. 1, 2002-01 ,pp. : 84-85

Informa Healthcare

Access to resources Recommend Favorite